INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
461.35 EUR
+60.75 (+15.16%)
We assign a fundamental rating of 6 out of 10 to 1ISRG. 1ISRG was compared to 65 industry peers in the Health Care Equipment & Supplies industry. 1ISRG gets an excellent profitability rating and is at the same time showing great financial health properties. 1ISRG is valued quite expensive, but it does show an excellent growth. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
1ISRG had a positive operating cash flow in the past year.
Each year in the past 5 years 1ISRG has been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1ISRG (14.19%) is better than 91.67% of its industry peers.
1ISRG's Return On Equity of 16.12% is amongst the best of the industry. 1ISRG outperforms 81.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.45%, 1ISRG belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ISRG is in line with the industry average of 9.72%.
The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(12.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
With an excellent Profit Margin value of 28.58%, 1ISRG belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a Operating Margin of 29.44%. This is amongst the best in the industry. 1ISRG outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG has a better Gross Margin (66.38%) than 75.00% of its industry peers.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
The number of shares outstanding for 1ISRG has been increased compared to 1 year ago.
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.42
WACC8.75%
2.3 Liquidity
1ISRG has a Current Ratio of 4.97. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
1ISRG has a better Current ratio (4.97) than 96.67% of its industry peers.
1ISRG has a Quick Ratio of 4.20. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.20, 1ISRG belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
The Revenue has grown by 22.18% in the past year. This is a very strong growth!
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 61.93, 1ISRG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as 1ISRG.
1ISRG is valuated expensively when we compare the Price/Earnings ratio to 26.37, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 53.92, the valuation of 1ISRG can be described as expensive.
63.33% of the companies in the same industry are cheaper than 1ISRG, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.20, 1ISRG is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.93 | ||
| Fwd PE | 53.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 63.33% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ISRG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.18 | ||
| EV/EBITDA | 52.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 15.85% in the coming years.
PEG (NY)3.11
PEG (5Y)5.39
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (10/30/2025, 7:00:00 PM)
461.35
+60.75 (+15.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap165.38B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target521.28 (12.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.55%
PT rev (3m)2.26%
EPS NQ rev (1m)3.15%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)5.63%
EPS NY rev (3m)9.92%
Revenue NQ rev (1m)1.61%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.93 | ||
| Fwd PE | 53.92 | ||
| P/S | 19.89 | ||
| P/FCF | 84.18 | ||
| P/OCF | 64.58 | ||
| P/B | 11.22 | ||
| P/tB | 11.45 | ||
| EV/EBITDA | 52.99 |
EPS(TTM)7.45
EY1.61%
EPS(NY)8.56
Fwd EY1.85%
FCF(TTM)5.48
FCFY1.19%
OCF(TTM)7.14
OCFY1.55%
SpS23.19
BVpS41.12
TBVpS40.28
PEG (NY)3.11
PEG (5Y)5.39
Graham Number83.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.75%
ROIC/WACC1.42
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 61.93 and the Price/Book (PB) ratio is 11.22.
What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 19.93% in the next year.